scispace - formally typeset
J

Jana M. Ellegast

Researcher at Harvard University

Publications -  21
Citations -  2736

Jana M. Ellegast is an academic researcher from Harvard University. The author has contributed to research in topics: Myeloid leukemia & Medicine. The author has an hindex of 9, co-authored 16 publications receiving 2466 citations. Previous affiliations of Jana M. Ellegast include Broad Institute & University of Zurich.

Papers
More filters
Journal ArticleDOI

5'-Triphosphate RNA Is the Ligand for RIG-I

TL;DR: It is demonstrated that the 5′-triphosphate end of RNA generated by viral polymerases is responsible for retinoic acid–inducible protein I (RIG-I)–mediated detection of RNA molecules in viruses known to be detected by MDA-5 such as the picornaviruses.
Journal ArticleDOI

Peripheral blood CD34+ cells efficiently engraft human cytokine knock-in mice

TL;DR: In this paper, the authors transplanted mobilized peripheral blood (PB) CD34+ cells in sublethally irradiated newborn and adult recipients and found that the transplanted PB cells showed higher engraftment levels in bone marrow, spleen, and PB in newborn transplanted MSTRG/MISTRG as compared with nonobese diabetic/severe combined immunodeficient Il2rg-/- or human SIRPα-transgenic Rag2-/-Il2rg+/- recipients.
Journal ArticleDOI

Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2

TL;DR: This work employs high-throughput screening to discover a lead chemical scaffold, the benzothiazolopyrimidones, that allosterically inhibits this oncogenic phosphatase by simultaneously engaging the C-SH2 and PTP domains.